Senhwa Biosciences Email Formats
Biotechnology Research • 
San Diego, California, United States • 21-50 Employees
Senhwa Biosciences Email Formats
Senhwa Biosciences uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@senhwabio.com), used 45.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@senhwabio.com | 54.6% |
{first name}{last name} | johndoe@senhwabio.com | 18.2% |
{last name} | doe@senhwabio.com | 18.2% |
{first initial} | j@senhwabio.com | 9.1% |
Key Contacts at Senhwa Biosciences
Chi-En Huang
Director, Clinical Department
Daniel Mccormick
Sr Director Of Clinical Operations
Taisen Soong
Ceo
Jocelyn Lee
Director Of Regulatory Affairs
Kaiwei Hsueh
Deputy Director
Gwen Chang
President Office Administrative Director
Tai Sen Soong
Ceo
Kacy Huang
Director Of Clinical Department
Company overview
| Headquarters | 10509 Vista Sorrento Parkway, Suite 201, San Diego, California 92121, US |
| Phone number | +886289119956 |
| Website | |
| Keywords | Precision Medicine, Targeted Cancer Therapy, Orphan Drug, First In Class, Synthetic Lethality, Dna Damage Response, Multiple Indications, Rescue Medication, Su2C-Cbcf Dream Team Drug |
| Founded | 2012 |
| Employees | 21-50 |
| Socials |
About Senhwa Biosciences
Senhwa Biosciences, Inc., a clinical stage drug development company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer. Currently 2 main compounds CX-5461 and CX-4945 are both first- in- class small molecule drugs and ongoing phase I/II clinical trials in Australia, Canada, United States, Korea and Taiwan. Senhwa’s CX-5461 is a G-quadruplexes (G4) stabilizer, causing DNA damage of tumor cells through a synthetic lethality (SL) approach in patients with BRCA1/2 mutations or HR deficiency (HRD). Senhwa's CX-4945 is a selective CK2 inhibitor and it has been shown to inhibit the phosphorylation of the DNA repair protein XRCC1 and subsequently enhance the activity of DNA damaging chemotherapy agents. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned to oversee the development of their compounds by collaborating with a diverse range of global investigators and service providers.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Senhwa Biosciences has 18 employees across 9 departments.
Departments
Number of employees
Funding Data
Senhwa Biosciences has never raised funding before.
Senhwa Biosciences Tech Stack
Discover the technologies and tools that power Senhwa Biosciences's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Programming languages
Analytics
Video players
UI frameworks
JavaScript libraries
Web frameworks
Font scripts
Tag managers
Singapore
Italy
Israel
Spain
Frequently asked questions
4.8
40,000 users
